Biond is an Israel-based biopharmaceutical company that develops and commercializes novel immunotherapies for the treatment of cancer and autoimmune diseases... Read more
Biond is an Israel-based biopharmaceutical company that develops and commercializes novel immunotherapies for the treatment of cancer and autoimmune diseases... Read more
News
Jun 02, 2026
Biospectrum Asia
Biond Biologics: Biond Biologics and Guangzhou-Israel Biotechnology Fund invest $8 M to advance oncology programmes in China
Oct 08, 2025
PR Newswire
Press Release: Biond Biologics : Biond Biologics Announces Initiation of a Phase 2 Study of BND-22 in Combination with anti-PD-1 therapy
Oct 30, 2024
Contract Pharma
Biond Biologics: Biond Biologics, Merck KGaA Collaborate on Phase 1 Trial for Solid Tumors
Jun 25, 2024
NoCamels
Biond Biologics: Novel Cancer Immunotherapy Drug Given To First Patient In Trial
Jun 24, 2024
StreetInsider
Press Release: Biond Biologics : Biond Biologics Announces First Patient Dosed with BND-35 in Phase 1 Clinical Trial
May 31, 2022
PR Newswire
Press Release: Biond Biologics : Biond Biologics Announces a Joint Poster Presentation With Sanofi at The ASCO 2022 Annual Meeting Presenting Pre-Clinical Translational Data of SAR444881 (BND-22)
May 23, 2022
StreetInsider
Press Release: Biond Biologics : Biond Biologics Announces First Patients Dosed with BND-22 (SAR444881) Combinations in Phase 1 Clinical Trial
Apr 20, 2022
FirstWord Pharma
Biond Biologics: Biond Biologics to Present at the Raymond James LILRB
Mar 21, 2022
FirstWord Pharma
Biond Biologics: Biond Biologics Announces Oral Presentation for BND-67, an Inhibitor of CD28 Shedding, a Potential Novel Resistance Mechanism to Anti PD-1 Therapy, at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Nov 03, 2021
BioSpace
Biond Biologics: Biond Biologics Announces Closing of $15 Million Series C Financing
Biond Biologics Competitors
1
2
3
4
5
6
7
8
9
10